DRUG RECALLS: NOVEMBER 2009


NOVEMBER 2009: FDA WANTS MORE BLACK BOX WARNINGS THAT ANTIDEPRESSANTS CAN ALSO INCREASE SUICIDAL THOUGHTS.

NOVEMBER 2009: CELEBREX FOUND TO INCREASE RISK OF HEART ATTACKS.

:TYPE 2 DIABETES DRUG REZULIN (TROGLITAZONE) CAUSED LIVER DISEASE AND LIVER FAILURE.

:PAINKILLER BEXTRA CAUSED SEROIUS SKIN REACTIONS AND CARDIOVASCULAR RISKS.

NOVEMBER 2009: SIBUTRAMINE (MERIDIA) USE FOR OBESITY RECALLED BECAUSE IT HAS A HIGH RISK OF HEART ATTACK, STROKE, RESUSCITATED CARDIAN ARREST, OR DEATH.

NOVEMBER 2009: ZETIA (EZETIMIBE) LOWERS BAD CHOLESTEROL WAS RECALLED BECAUSE IT CAUSED HEART ATTACKS, STROKES, AND DEATH. ALSO FAILS TO SHOW BENEFIT.

NOVEMBER 2009: PLAVIX (CLOPIDOGREL) A ANTI-CLOTTING CANNOT BE TAKEN WITH PRILOSEC (OMEPRAZOLE) AND OTHER PROTON-PUMP INHIBITORS BECAUSE IF REDUCES EFFECTIVENESS OF PLAVIX.